UVA tests eConsults/eReferrals model

 

The University of Virginia Health System (U.Va) has begun piloting a program testing the eConsults/eReferrals model, which utilizes digital platforms to speed patient access to specialists.

The university is among five academic medical centers testing the model thanks to a $7 million cumulative grant from the Center for Medicare and Medicaid Innovation. The UVa program aims to make available additional appointments with specialists for patients with more complex medical conditions. Specifically, eConsults or eReferrals will allow specialists to answer more straightforward questions in some cases without requiring an appointment, according to a press release.

As it rolls out the program, Va is focusing on four specialties: endocrinology, cardiology, digestive health and neurology.

“If you can answer the least complex questions using this model and reduce appointments by 10 percent, you can open up more appointments for patients who will truly benefit from face-to-face interactions with specialty physicians,” said Chris Ghaemmaghami, MD, UVa.’s chief medical officer, in a statement.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.